Concepedia

Manolo Mugnaini

MM

22

Publications

1.4K

Citations

20

H-Index

1992

Active since

Affiliations

GlaxoSmithKline (Italy)(Current)

GlaxoSmithKline (United Kingdom)

University of Milan

Aptuit (Italy)

Research Triangle Park Foundation

Manolo Mugnaini is an author at GlaxoSmithKline (Italy) specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

Publications per year

1992–2015

22

Publications

22

Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement

Cecilia Gotti, Stefania Guiducci, Vincenzo Tedesco et al. · Journal of Neuroscience · 2010 · 226 citations · Full text

The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection

Corrado Corti, Giuseppe Battaglia, Gemma Molinaro et al. · Journal of Neuroscience · 2007 · 201 citations · Full text

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

Graham E. Searle, John D. Beaver, Robert A. Comley et al. · Biological Psychiatry · 2010 · 149 citations

, , +10

Upregulation of [<sup>3</sup>H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of α7 or α6 subunit mRNA: an autoradiography and<i>in situ</i>hybridization study in rat brain

Manolo Mugnaini, Michela Tessari, G. Tarter et al. · European Journal of Neuroscience · 2002 · 88 citations

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines:  A Series of Potent and Selective Dopamine D<sub>3</sub>Receptor Antagonists

Fabrizio Micheli, Giorgio Bonanomi, Frank E. Blaney et al. · Journal of Medicinal Chemistry · 2007 · 83 citations · Full text

Rows per page

1–5 of 22